Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine eye drops for prevention and acute treatment of vernal keratoconjunctivitis
2006-003689-32Phase 2Completed
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Jan 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cyclosporine in Vernal Keratoconjunctivitis (VKC) (2 arms), sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: Reduction of relapses. Started Jan 2007; status: completed.
02
Drugs
cyclosporine
03
Conditions
Vernal Keratoconjunctivitis (VKC)
Beyond the preview
Go deeper on 2006-003689-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003689-32.